Cointime

Download App
iOS & Android

Innovent Biologics

company
Funding Round
Post-IPO Equity
Money Raised
$ 2.42B
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Sanofi - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Nov 29, 2016 Series D $ 260M Milestone Detail
Nov 16, 2012 Series B $ 30M Lilly Asia Ventures Detail
Jan 22, 2015 Series C $ 115M Lilly Asia Ventures Detail
Apr 27, 2018 Series E $ 150M Lilly Asia Ventures Detail